Walgreens Boots Alliance(WBA) Prnewswire·2025-02-20 10:45Core Viewpoint - Walgreens Boots Alliance, Inc. is facing allegations of issuing materially false and misleading statements regarding its compliance with federal laws governing prescription medication dispensation and reimbursement during the class period from April 2, 2020, to January 16, 2025 [1] Group 1: Allegations and Legal Context - The complaint alleges that Walgreens continued to engage in widespread violations of federal law despite its claims of improved regulatory compliance [1] - The conduct of Walgreens is said to expose the company to increased risks of regulatory scrutiny, civil liability, and reputational harm [1] - Revenues from the sale of prescription medications are claimed to be unsustainable due to their derivation from unlawful conduct [1] Group 2: Shareholder Information - Shareholders who purchased shares of WBA during the specified class period are encouraged to register for potential lead plaintiff appointment, with a deadline set for March 31, 2025 [2] - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2] Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3]